| 1 |
31960518 | Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level. | 2020 Mar |
3 |
| 2 |
32646946 | Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas. | 2020 Aug |
3 |
| 3 |
33778723 | Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas. | 2020 Jul |
3 |
| 4 |
29662077 | Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. | 2018 Apr 16 |
1 |
| 5 |
28578659 | Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. | 2017 Jun 2 |
2 |
| 6 |
27144334 | Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters. | 2016 Jun 7 |
1 |
| 7 |
27437179 | Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. | 2016 |
2 |
| 8 |
25251602 | Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. | 2015 Jan |
1 |
| 9 |
25706986 | Metabolic reprogramming in mutant IDH1 glioma cells. | 2015 |
1 |
| 10 |
23456655 | GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients. | 2013 May |
1 |
| 11 |
6089434 | [The effect of impairment of neuroregulation on the activity of redox enzymes in the smooth muscles of the pigeon stomach]. | 1984 May-Jun |
1 |